Litigating Civil Antitrust Matters In The United States
Select a format
Select subscription type
Terms & conditions
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing email@example.com; or returning the invoice marked "CANCEL".
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
This book offers both lawyer and non-lawyer the opportunity to understand the various types of civil antitrust litigation that is active in the United States. The book is organized by legal theory and starts with by addressing the most common type of antitrust litigation, which is litigation arising under Section 1 of the Sherman Act. The book then addresses Section 2 (monopolies) and the Robinson-Patman Act, before devoting two chapters to the intersection of antitrust and intellectual property, both generally and specifically with respect to the pharmaceutical industry. The book concludes by addressing issues associated with litigating civil antitrust claims brought by the federal government.
The focus is on trying to make the chapters easy to read while still providing sufficient case citations so that a lawyer who wishes to pursue a more in-depth focus on a topic would have the leading cases at his or her disposal. The book will be updated in order to account for new developments in the law.
The 2018 edition ISBN is 9781522147954.
eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® for further legal research options. A valid subscription to Lexis+® is required to access this content.
Table of contents
• Chapter 1 - Sherman Act 1 Claims
• Chapter 2 - Sherman Act 2 Claims
• Chapter 3 - The Robinson-Patman Act
• Chapter 4 - Antitrust Class Actions
• Chapter 5 - Antitrust Issues Raised by the Assertion of Intellectual Property Rights
• Chapter 6 - Pharmaceutical Antitrust: Rethinking First Principles in the Context of Hatch-Waxman
• Chapter 7 - Litigating Against the Government
New!PreorderBernhardt's California Real Estate LawsNew!Estimated: February 16, 2023$255.00
New!California Corporations Code and Commercial Code with Securities Rules and ReleasesNew!Estimated: December 15, 2022$183.00
New!PreorderDeering's California Desktop Code Set SoftboundNew!Estimated: December 30, 2022$507.00